• How the Lilly-Adverum deal came together; Captain T Cell reels in €20M Endpoints News Mon, 17 Nov 2025 16:10:00 GMT
• Lundbeck takes the lead in acquisition race for Irish company medwatch.com Mon, 17 Nov 2025 14:15:33 GMT
• Lundbeck battles Irish Alkermes over narcolepsy company medwatch.com Mon, 17 Nov 2025 12:00:00 GMT
• Truist Raises Price Target on Alkermes to $55 From $50, Keeps Buy Rating MarketScreener Mon, 17 Nov 2025 11:46:23 GMT
• Alkermes (ALKS) Faces Potential Termination of Acquisition Agree GuruFocus Mon, 17 Nov 2025 11:34:52 GMT
• Avadel Board Of Directors Declares Lundbeck Proposal A “Company Superior Proposal” TradingView Mon, 17 Nov 2025 10:47:03 GMT
• Truist Securities raises Alkermes stock price target to $55 on positive trial data Investing.com Mon, 17 Nov 2025 10:34:02 GMT
• risk vs reward if holding onto alkermes plc - market volume report & free weekly chart analysis and trade guides newser.com Sun, 16 Nov 2025 20:43:54 GMT
• relative strength of alkermes plc in sector analysis - 2025 endofyear setup & expert verified movement alerts newser.com Sun, 16 Nov 2025 11:09:07 GMT
• applying elliott wave theory to alkermes plc - quarterly market review & long-term growth portfolio plans newser.com Sun, 16 Nov 2025 08:48:51 GMT
• How strong is Alkermes plc (8AK) stock earnings growth - Earnings Growth Report & Low Risk Entry Point Guides newser.com Sun, 16 Nov 2025 06:47:37 GMT
• how alkermes plc (8ak) stock valuation compares with sector - july 2025 reactions & consistent profit trade alerts newser.com Sun, 16 Nov 2025 06:01:29 GMT
• avadel gets acquisition proposal from lundbeck weeks after inking agreement with alkermes MSN Sun, 16 Nov 2025 05:48:07 GMT
• what data driven models say about alkermes plc’s future - july 2025 sector moves & real-time volume surge alerts newser.com Sun, 16 Nov 2025 05:16:46 GMT
• alkermes reviewing options after lundbeck makes unsolicited bid for avadel MSN Sun, 16 Nov 2025 04:36:19 GMT
• what moving averages say about alkermes plc - 2025 top gainers & technical confirmation trade alerts newser.com Sun, 16 Nov 2025 00:33:07 GMT
• how strong is alkermes plc (8ak) stock earnings growth - july 2025 opening moves & real-time buy signal alerts newser.com Sat, 15 Nov 2025 18:47:37 GMT
• what moving averages say about alkermes plc - market performance report & weekly hot stock watchlists newser.com Sat, 15 Nov 2025 18:35:05 GMT
• risk vs reward if holding onto alkermes plc - ipo watch & risk managed investment strategies newser.com Sat, 15 Nov 2025 09:54:42 GMT
• Will Analyst Skepticism on Alixorexton Reshape Alkermes' (ALKS) Competitive Strategy in Narcolepsy? simplywall.st Sat, 15 Nov 2025 09:40:44 GMT
• how high can alkermes plc stock go - july 2025 review & weekly high potential stock alerts newser.com Sat, 15 Nov 2025 09:30:16 GMT
• comparing alkermes plc in custom built stock radars - options play & ai powered market entry strategies newser.com Sat, 15 Nov 2025 08:06:49 GMT
• avadel gets acquisition proposal from lundbeck weeks after inking agreement with alkermes MSN Sat, 15 Nov 2025 05:53:33 GMT
• alkermes shares tumble as sleep disorder drug shows limited advantage over rival MSN Sat, 15 Nov 2025 05:29:18 GMT
• risk vs reward if holding onto alkermes plc - market growth report & pattern based trade signal system newser.com Sat, 15 Nov 2025 01:17:05 GMT
• STATE STREET CORP's Strategic Acquisition of Alkermes PLC Shares GuruFocus Sat, 15 Nov 2025 00:34:57 GMT
• H.C. Wainwright Maintains Alkermes(ALKS.US) With Hold Rating, Maintains Target Price $46 富途牛牛 Sat, 15 Nov 2025 00:33:00 GMT
• alkermes responds to potential rival bid for avadel from lundbeck by investing.com Investing.com Nigeria Sat, 15 Nov 2025 00:29:40 GMT
• what data driven models say about alkermes plc’s future - 2025 bull vs bear & consistent return investment signals newser.com Sat, 15 Nov 2025 00:28:23 GMT
• will alkermes plc stock rally after fed decisions - july 2025 breakouts & weekly high potential stock alerts newser.com Sat, 15 Nov 2025 00:05:11 GMT
• applying elliott wave theory to alkermes plc - stop loss & real-time volume surge alerts newser.com Fri, 14 Nov 2025 23:52:04 GMT
• Another Bidding War As Lundbeck Swoops In On Alkermes/Avadel Deal Citeline News & Insights Fri, 14 Nov 2025 21:45:25 GMT
• To Wall Street, a new bidding war puts Alkermes in a tough spot BioPharma Dive Fri, 14 Nov 2025 21:43:48 GMT
• A New Buyout Battle Is Brewing In Biotech; One Stock Is Up 20% Investor's Business Daily Fri, 14 Nov 2025 21:04:00 GMT
• applying elliott wave theory to alkermes plc - trade exit report & technical entry and exit alerts newser.com Fri, 14 Nov 2025 20:45:40 GMT
• how alkermes plc (8ak) stock valuation compares with sector - take profit & weekly breakout stock alerts newser.com Fri, 14 Nov 2025 20:09:01 GMT
• how high can alkermes plc stock go - july 2025 fed impact & precise buy zone tips newser.com Fri, 14 Nov 2025 19:26:14 GMT
• avadel pharmaceuticals attracts rival bids in buyout showdown Finimize Fri, 14 Nov 2025 19:13:34 GMT
• truist thinks alkermes can make counter offer acceptable to avadel board TipRanks Fri, 14 Nov 2025 18:34:21 GMT
• is alkermes plc forming a bottoming base - 2025 support & resistance & low risk entry point guides newser.com Fri, 14 Nov 2025 16:49:33 GMT
• Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal Benzinga Fri, 14 Nov 2025 16:37:57 GMT
• H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal The Wall Street Journal Fri, 14 Nov 2025 16:03:00 GMT
• Lundbeck tries to upend Alkermes' takeout of sleep drug developer Avadel FirstWord Pharma Fri, 14 Nov 2025 15:14:23 GMT
• pharmalittle: we're reading about a merck acquisition, novo facing shareholder backlash, and more statnews.com Fri, 14 Nov 2025 14:50:24 GMT
• lundbeck makes unsolicited offer for avadel pharmaceuticals The Pharma Letter Fri, 14 Nov 2025 14:38:21 GMT
• Lundbeck disrupts Alkermes' planned $2.1B purchase of Avadel with higher bid Fierce Pharma Fri, 14 Nov 2025 14:29:52 GMT
• Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel BioSpace Fri, 14 Nov 2025 13:58:45 GMT
• Avadel Considers Lundbeck's Proposal Amid Alkermes Agreement (AL GuruFocus Fri, 14 Nov 2025 13:52:30 GMT
• Alkermes (ALKS) Evaluates Options Following Avadel Pharmaceutica GuruFocus Fri, 14 Nov 2025 13:50:19 GMT
• alkermes responds to potential rival bid for avadel from lundbeck by investing.com Investing.com South Africa Fri, 14 Nov 2025 13:34:21 GMT
• Lundbeck makes bid for Avadel, trying to displace Alkermes pharmaphorum Fri, 14 Nov 2025 13:33:44 GMT
• applying elliott wave theory to alkermes plc - weekly trading summary & free expert approved momentum trade ideas newser.com Fri, 14 Nov 2025 13:29:47 GMT
• Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel TradingView Fri, 14 Nov 2025 13:11:14 GMT
• Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes Stocktwits Fri, 14 Nov 2025 12:56:15 GMT
• Alkermes responds to competing offer for Avadel from Lundbeck StreetInsider Fri, 14 Nov 2025 12:47:31 GMT
• Alkermes (NASDAQ: ALKS) notes Avadel must give 5 Business Days’ notice, negotiate Stock Titan Fri, 14 Nov 2025 12:45:00 GMT
• is alkermes plc (8ak) stock considered safe haven - july 2025 analyst calls & long hold capital preservation plans Fundação Cultural do Pará Fri, 14 Nov 2025 12:13:10 GMT
• Avadel climbs as Lundbeck outbids Alkermes in latest bidding war Seeking Alpha Fri, 14 Nov 2025 11:57:52 GMT
• avadel climbs as lundbeck outbids alkermes (avdl:nasdaq) Seeking Alpha Fri, 14 Nov 2025 11:57:52 GMT
• Lundbeck sparks bidding war with Alkermes; Pfizer closes Metsera deal Yahoo Finance Fri, 14 Nov 2025 11:06:00 GMT
• wells fargo maintains alkermes(alks.us) with buy rating, cuts target price to $37 富途牛牛 Fri, 14 Nov 2025 06:32:00 GMT
• Wells Fargo Lowers Price Target for Alkermes (ALKS) to $37 | ALKS Stock News GuruFocus Fri, 14 Nov 2025 06:16:13 GMT
• is alkermes plc (8ak) stock at risk of policy regulation - trend reversal & expert verified stock movement alerts newser.com Thu, 13 Nov 2025 23:01:06 GMT
• Alkermes at Stifel 2025: Strategic Insights on Narcolepsy Drug Investing.com Thu, 13 Nov 2025 21:09:34 GMT
• Alkermes Shares Phase 2 Results of Orexin 2 Receptor Agonist in Narcolepsy Type 2 Sleep Review Thu, 13 Nov 2025 19:59:30 GMT
• how strong is alkermes plc (8ak) stock earnings growth - market growth review & high accuracy buy signal tips newser.com Thu, 13 Nov 2025 18:06:29 GMT
• risk vs reward if holding onto alkermes plc - july 2025 decliners & capital efficient trade techniques newser.com Thu, 13 Nov 2025 17:34:40 GMT
• wells fargo lowers price target for alkermes (alks) to $37 | alks stock news GuruFocus Thu, 13 Nov 2025 16:57:39 GMT
• alixorexton for treatment of narcolepsy type 2: new positive phase 2 data Psychiatric Times Thu, 13 Nov 2025 15:47:42 GMT
• Positive Phase II results for Alkermes’ alixorexton The Pharma Letter Thu, 13 Nov 2025 14:54:28 GMT
• deutsche bank lowers price target on alkermes to $45 from $55, keeps buy rating MarketScreener Thu, 13 Nov 2025 13:47:44 GMT
• A Look at Alkermes's Valuation Following Promising Vibrance-2 Phase 2 Results for Alixorexton simplywall.st Thu, 13 Nov 2025 13:43:46 GMT
• Alkermes Pushes Narcolepsy Program to Phase III With ‘Highly Competitive’ Mid-Stage Data BioSpace Thu, 13 Nov 2025 13:38:02 GMT
• alkermes-avadel pharmaceuticals deal's hsr deadline set to expire dec. 8 MLex Thu, 13 Nov 2025 13:03:00 GMT
• analyst david hoang of deutsche bank lowers alks price target | alks stock news GuruFocus Thu, 13 Nov 2025 12:16:09 GMT
• Alkermes stock rating reiterated at Outperform by Mizuho on narcolepsy drug data Investing.com Nigeria Thu, 13 Nov 2025 12:11:44 GMT
• alkermes price target lowered to $45 from $55 at deutsche bank TipRanks Thu, 13 Nov 2025 12:02:24 GMT
• Alkermes (ALKS) Buy Rating Reiterated by Truist Securities | ALKS Stock News GuruFocus Thu, 13 Nov 2025 10:41:46 GMT
• Alkermes: Hold Rating Amid Mixed Trial Results and Uncertain Market Position TipRanks Thu, 13 Nov 2025 10:04:51 GMT
• A Look at Alkermes's Valuation Following Positive Phase 2 Alixorexton Results in Narcolepsy Type 2 Yahoo Finance Thu, 13 Nov 2025 08:15:32 GMT
• will alkermes plc stock rally after fed decisions - exit point & weekly high return opportunities newser.com Thu, 13 Nov 2025 05:36:29 GMT
• alkermes reports positive phase 2 results for narcolepsy drug by investing.com Investing.com Nigeria Thu, 13 Nov 2025 05:33:38 GMT
• how alkermes plc (8ak) stock valuation compares with sector - july 2025 reactions & consistent profit trade alerts newser.com Thu, 13 Nov 2025 04:18:57 GMT
• risk vs reward if holding onto alkermes plc - analyst downgrade & safe capital preservation plans newser.com Thu, 13 Nov 2025 03:04:12 GMT
• how high can alkermes plc stock go - july 2025 gainers & free reliable trade execution plans newser.com Thu, 13 Nov 2025 02:56:53 GMT
• alkermes stock maintains buy rating at stifel after narcolepsy drug results by investing.com Investing.com South Africa Thu, 13 Nov 2025 02:41:14 GMT
• why alkermes plc stock appeals to analysts - july 2025 trends & community verified trade signals newser.com Thu, 13 Nov 2025 01:11:06 GMT
• applying elliott wave theory to alkermes plc - rate cut & reliable breakout forecasts newser.com Thu, 13 Nov 2025 00:17:24 GMT
• alkermes stock holds steady as bofa maintains neutral rating after mixed trial data Investing.com Nigeria Thu, 13 Nov 2025 00:14:08 GMT
• Alkermes’ alixorexton hits endpoints in narcolepsy phase II BioWorld MedTech Wed, 12 Nov 2025 21:55:31 GMT
• Alkermes Two-For-Two In Narcolepsy As Alixorexton Succeeds In NT2 Trial Citeline News & Insights Wed, 12 Nov 2025 21:45:50 GMT
• Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2 Applied Clinical Trials Wed, 12 Nov 2025 19:31:36 GMT
• alkermes stock holds buy rating at td cowen on solid narcolepsy drug data Investing.com UK Wed, 12 Nov 2025 19:13:03 GMT
• alkermes stock holds steady as bofa maintains neutral rating after mixed trial data Investing.com UK Wed, 12 Nov 2025 19:13:02 GMT
• Alkermes claims success in mid-stage narcolepsy study, but investors unimpressed FirstWord Pharma Wed, 12 Nov 2025 18:58:51 GMT
• alkermes (alks) buy rating reiterated by truist securities | alks stock news GuruFocus Wed, 12 Nov 2025 18:38:18 GMT
• Alkermes (ALKS) Shares Decline Despite Positive Phase 2 Study Re GuruFocus Wed, 12 Nov 2025 18:17:40 GMT
• alkermes eyes global phase 3 trial after encouraging data from sleep disorder study Benzinga Wed, 12 Nov 2025 17:46:56 GMT
• alkermes nt2 effect magnitude below ‘bullish expectations,’ says h.c. wainwright TipRanks Wed, 12 Nov 2025 17:30:17 GMT
• alkermes stock maintains buy rating at stifel after narcolepsy drug results Investing.com India Wed, 12 Nov 2025 17:11:18 GMT
• Alkermes (ALKS) Phase 2 Study Results Generate Mixed Reactions GuruFocus Wed, 12 Nov 2025 17:04:37 GMT
• will alkermes plc stock rally after fed decisions - market activity recap & free community consensus stock picks newser.com Wed, 12 Nov 2025 16:48:18 GMT
• alkermes’ strong position and misinterpreted data: justifying a buy rating TipRanks Wed, 12 Nov 2025 16:21:55 GMT
• Narcolepsy race heats up with Alkermes’ OX2R NT2 data but investors spooked Clinical Trials Arena Wed, 12 Nov 2025 16:18:48 GMT
• Alkermes stock holds Buy rating at Truist after positive Vibrance-2 data Investing.com Wed, 12 Nov 2025 15:52:07 GMT
• Alkermes (ALKS) Shares Fall Despite Positive Trial Results for S GuruFocus Wed, 12 Nov 2025 15:06:22 GMT
• alkermes phase 2 narcolepsy study details ‘scant,’ says truist TipRanks Wed, 12 Nov 2025 15:03:04 GMT
• Alkermes breaks new ground in narcolepsy with orexin drug pharmaphorum Wed, 12 Nov 2025 14:35:26 GMT
• risk vs reward if holding onto alkermes plc - july 2025 big picture & high return stock watch alerts newser.com Wed, 12 Nov 2025 14:33:26 GMT
• alkermes posts another mid-stage success for orexin drug in narcolepsy FirstWord Pharma Wed, 12 Nov 2025 14:32:20 GMT
• Alkermes races to phase 3 after posting another narcolepsy win Fierce Biotech Wed, 12 Nov 2025 14:30:20 GMT
• Alkermes falls after trial data for sleep drug (ALKS:NASDAQ) Seeking Alpha Wed, 12 Nov 2025 14:01:17 GMT
• alkermes stock tumbles after narcolepsy drug trial results Investing.com Wed, 12 Nov 2025 14:00:00 GMT
• alkermes’ alixorexton shows promising results in nt2 patients, justifying buy rating TipRanks Wed, 12 Nov 2025 13:53:29 GMT
• Alkermes (ALKS) Reports Positive Phase 2 Results for Narcolepsy Treatment GuruFocus Wed, 12 Nov 2025 13:10:38 GMT
• alkermes reports positive phase 2 results for narcolepsy drug by investing.com Investing.com Australia Wed, 12 Nov 2025 13:01:36 GMT
• alkermes says ‘positive’ results from vibrance-2 phase 2 study of alixorexton TipRanks Wed, 12 Nov 2025 13:00:28 GMT
• Alkermes shares tumble as sleep disorder drug shows limited advantage over rival TradingView Wed, 12 Nov 2025 12:41:13 GMT
• alkermes' narcolepsy drug shows promise in mid-stage trial TradingView Wed, 12 Nov 2025 12:41:13 GMT
• Alkermes' narcolepsy drug meets main goal in a mid-stage trial Yahoo Wed, 12 Nov 2025 12:35:29 GMT
• Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Ty... PR Newswire Wed, 12 Nov 2025 12:30:00 GMT
• Alkermes (NASDAQ: ALKS) oral orexin 2 agonist met dual endpoints in NT2 trial Stock Titan Wed, 12 Nov 2025 12:30:00 GMT
• risk vs reward if holding onto alkermes plc - 2025 geopolitical influence & ai forecast for swing trade picks newser.com Wed, 12 Nov 2025 08:33:26 GMT
• relative strength of alkermes plc in sector analysis - 2025 endofyear setup & expert verified movement alerts newser.com Wed, 12 Nov 2025 08:12:36 GMT
• how strong is alkermes plc (8ak) stock earnings growth - weekly profit analysis & breakout confirmation alerts newser.com Wed, 12 Nov 2025 05:11:55 GMT
• what data driven models say about alkermes plc’s future - share buyback & growth focused stock pick reports newser.com Tue, 11 Nov 2025 18:45:41 GMT
• alkermes stock initiated with buy rating by truist on sleep disorder drug potential Investing.com Nigeria Tue, 11 Nov 2025 12:07:31 GMT
• truist initiates alkermes at buy with $50 price target MarketScreener Tue, 11 Nov 2025 11:30:24 GMT
• what moving averages say about alkermes plc - trade analysis summary & free fast gain swing trade alerts newser.com Tue, 11 Nov 2025 11:16:47 GMT
• alkermes (alks) receives a hold from h.c. wainwright The Globe and Mail Tue, 11 Nov 2025 01:25:54 GMT
• how alkermes plc (8ak) stock valuation compares with sector - 2025 price targets & scalable portfolio growth ideas newser.com Mon, 10 Nov 2025 10:54:58 GMT
Alkermes plc(NASDAQ:ALKS) 
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA (aripiprazole lauroxil), an e...
Website: http://www.alkermes.com
Founded: 1987
Full Time Employees: 2,235
Sector: Healthcare
Industry: Biotechnology